Archives - Saturday 23 August 2008
Popular pill for cholesterol linked to cancer
Published on Saturday 23 August 2008 - 23:36 - http://archive.gulfnews.com/A pill that lowers cholesterol has been linked to an increased risk of cancer.
Medication has cancer risk says new study
Published on Saturday 23 August 2008 - 23:05 - http://www.radionz.co.nz/A new study has found that the use of a popular cholesterol-lowering medication available in New Zealand appears to raise the risk of cancer.
FDA Investigates Cholesterol Drug
Published on Saturday 23 August 2008 - 22:55 - http://www.pharmiweb.com/OfficialSpin
FDA Investigates Cholesterol Drug
Published on Saturday 23 August 2008 - 21:12 - http://www.postchronicle.com/Vytorin is a combination of simvastatin, marketed as Zocor, and ezetimibe, marketed as Zetia. It was approved as a combination drug in 2004 to......
FDA investigates cholesterol drug
Published on Saturday 23 August 2008 - 16:17 - http://www.pharmiweb.com/Political Gateway
FDA investigates cholesterol drug
Published on Saturday 23 August 2008 - 15:16 - http://www.pharmiweb.com/Webindia123
FDA investigates cholesterol drug
Published on Saturday 23 August 2008 - 14:52 - http://www.pharmiweb.com/Therapeutics Daily
FDA Needs Nine More Months to Study Vytorin, Cancer Link
Published on Saturday 23 August 2008 - 14:29 - http://medheadlines.com/Questions have arisen over the past several months as to the efficacy and safety of the popular cholesterol-lowering prescription drug, Vytorin, which is a combination of ezetimibe and...
FDA investigates possible Vytorin link to cancer
Published on Saturday 23 August 2008 - 13:17 - http://www.physorg.com/(AP) -- Federal drug safety regulators said Thursday they are investigating whether the cholesterol-lowering drug Vytorin can increase patients' risk of developing cancer.
Lawmakers Demand Study Data on Vytorin Cancer Risk
Published on Saturday 23 August 2008 - 09:00 - http://www.memphisdailynews.com/TRENTON, N.J. (AP) - A congressional committee is demanding that the makers of controversial cholesterol drug Vytorin, Merck & Co. and Schering-Plough....
